08/12/2025
Vietnam has officially approved the use of a Russian-developed cancer vaccine that targets fourteen of the most serious forms of cancer. This marks a major step toward offering advanced, affordable cancer care across the country.
The vaccine is designed to support the body’s immune system in recognizing and attacking cancer cells. Unlike chemotherapy, which kills both healthy and unhealthy cells, this vaccine works by teaching the immune system how to spot cancer without harming other tissues. It is a form of immunotherapy, which is quickly becoming a powerful new tool in cancer treatment.
The vaccine has shown promising results in clinical trials for cancers like lung, liver, colon, breast, and pancreatic cancer. It is not a cure, but it can slow tumor growth, improve survival rates, and reduce the need for more aggressive treatments. Patients receiving the vaccine have reported fewer side effects and improved quality of life.
What makes this development important is accessibility. Vietnam plans to roll out the vaccine across public hospitals and health centers at a price much lower than other global treatments. This opens the door for thousands of families who previously could not afford high-end cancer therapies.
Health officials say this approval will also help reduce strain on the country’s medical system. More patients can be treated earlier and more effectively, improving long-term outcomes.
This step reflects a growing focus on science-backed, cost-effective health solutions for serious diseases. With strong public health planning and global partnerships, Vietnam is showing how modern care can reach more people without high costs.
A vaccine for cancer once sounded impossible. Now it is part of a national plan to fight back with science.